MDL (drug)
MDL (short for Methoxy Dihydro Lysergol) is a metabolite of the drug nicergoline.
≈ 1 min read
MDL (drug). encyclopegia.org, snapshot enwiki-001370679924. /a/mdl-drug
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
MDL (short for Methoxy Dihydro Lysergol) is a metabolite of the drug nicergoline. It is member of the ergoline family and is a dehydrogenated and methoxylated lysergol (a lysergol in which the double bond between carbon atoms 9 and 10 has been hydrogenated and a methoxy group is attached to the 10th carbon atom in the α-configuration).
MDL is formed as a result of the N-demethylation of the metabolite MMDL; the enzyme CYP2D6 plays a key role in this chemical reaction, and its individual functional activity determines the efficiency with which this drug is metabolised in the body.
See also
Substituted ergoline
Text derived from https://en.wikipedia.org/w/index.php?oldid=1370679924 under CC BY-SA 4.0; modifications have been made.